↓ Skip to main content

Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates

Overview of attention for article published in Frontiers in oncology, February 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
6 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
Published in
Frontiers in oncology, February 2023
DOI 10.3389/fonc.2023.1124039
Pubmed ID
Authors

Ye-Jin Kim, Wei Li, Doncho V. Zhelev, John W. Mellors, Dimiter S. Dimitrov, Du-San Baek

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 8%
Professor 1 8%
Researcher 1 8%
Student > Doctoral Student 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 8 62%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 15%
Unspecified 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Social Sciences 1 8%
Unknown 8 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2023.
All research outputs
#6,606,547
of 25,707,225 outputs
Outputs from Frontiers in oncology
#2,181
of 22,767 outputs
Outputs of similar age
#114,954
of 425,450 outputs
Outputs of similar age from Frontiers in oncology
#84
of 1,417 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 22,767 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,450 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 1,417 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.